Cargando…
Emergency department implementation of monoclonal antibody infusion for the treatment of coronavirus disease 2019: A template for rapid deployment
Monoclonal antibody (mAb) therapy can improve coronavirus disease 2019 outcomes when infused early in select patients. We sought to rapidly create and implement a program for emergency department (ED) mAb infusion to aid care. Using multiple strategies and actions—education, selection criteria, scre...
Autores principales: | Woltemate, Thomas J., Wadas, Richard J., McCreary, Erin K., Bariola, Ryan, Minnier, Tami, Marroquin, Oscar C., Schmidhofer, Mark, Albin, Debbie, Angus, Derek C., Yealy, Donald M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448483/ https://www.ncbi.nlm.nih.gov/pubmed/34568870 http://dx.doi.org/10.1002/emp2.12550 |
Ejemplares similares
-
Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic
por: Bariola, J Ryan, et al.
Publicado: (2021) -
Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Bariola, J Ryan, et al.
Publicado: (2021) -
Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 days
por: McCreary, Erin K., et al.
Publicado: (2022) -
Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19
por: McCreary, Erin K., et al.
Publicado: (2022) -
Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era
por: McCreary, Erin K, et al.
Publicado: (2022)